FIRM FIXED PRICE

NOVARTIS PHARMACEUTICALS CORPORATION - RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA

PIID: 36C25026N0254

Signed Date: Dec 31, 2025Effective Date: Jan 1, 2026End Date: Closed on Jan 31, 2026

Award $

$316K

Vendor

NOVARTIS PHARMACEUTICALS CORPORATION

NAICS

325412

Signed Date

Dec 31, 2025

Key Details

Dollars Obligated

$316,159.88

Base & All Options

$316,159.88

Awarding Agency

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

EAST HANOVER, NJ, 079361016, CD-NJ-11

RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA

On Dec 31, 2025, Department of Veterans Affairs obligated $316,159.88 to NOVARTIS PHARMACEUTICALS CORPORATION for radiopharmaceuticals pluvicto / lutathera. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in EAST HANOVER, NJ.